| Graft-versus-host disease JLM Ferrara, JE Levine, P Reddy, E Holler The Lancet 373 (9674), 1550-1561, 2009 | 3041 | 2009 |
| International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium AC Harris, R Young, S Devine, WJ Hogan, F Ayuk, U Bunworasate, ... Biology of Blood and Marrow Transplantation 22 (1), 4-10, 2016 | 626 | 2016 |
| Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and … E Holler, P Butzhammer, K Schmid, C Hundsrucker, J Koestler, K Peter, ... Biology of Blood and Marrow Transplantation 20 (5), 640-645, 2014 | 534 | 2014 |
| Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia EJ Orlando, X Han, C Tribouley, PA Wood, RJ Leary, M Riester, JE Levine, ... Nature medicine 24 (10), 1504-1506, 2018 | 467 | 2018 |
| A biomarker panel for acute graft-versus-host disease S Paczesny, OI Krijanovski, TM Braun, SW Choi, SG Clouthier, R Kuick, ... Blood, The Journal of the American Society of Hematology 113 (2), 273-278, 2009 | 460 | 2009 |
| Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression JD Geiger, RJ Hutchinson, LF Hohenkirk, EA McKenna, GA Yanik, ... Cancer research 61 (23), 8513-8519, 2001 | 420 | 2001 |
| Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency DA Williams, W Tao, F Yang, C Kim, Y Gu, P Mansfield, JE Levine, ... Blood, The Journal of the American Society of Hematology 96 (5), 1646-1654, 2000 | 418 | 2000 |
| ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death MT Vander Lugt, TM Braun, S Hanash, J Ritz, VT Ho, JH Antin, Q Zhang, ... New England Journal of Medicine 369 (6), 529-539, 2013 | 411 | 2013 |
| Integrative clinical sequencing in the management of refractory or relapsed cancer in youth RJ Mody, YM Wu, RJ Lonigro, X Cao, S Roychowdhury, P Vats, KM Frank, ... Jama 314 (9), 913-925, 2015 | 382 | 2015 |
| Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease JLM Ferrara, AC Harris, JK Greenson, TM Braun, E Holler, T Teshima, ... Blood, The Journal of the American Society of Hematology 118 (25), 6702-6708, 2011 | 355 | 2011 |
| EBMT− NIH− CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment HM Schoemans, SJ Lee, JL Ferrara, D Wolff, JE Levine, KR Schultz, ... Bone marrow transplantation 53 (11), 1401-1415, 2018 | 325 | 2018 |
| Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation JE Levine, T Braun, SL Penza, P Beatty, K Cornetta, R Martino, ... Journal of Clinical Oncology 20 (2), 405-412, 2002 | 320 | 2002 |
| Donor leukocyte infusions in acute lymphocytic leukemia RH Collins Jr, S Goldstein, S Giralt, J Levine, D Porter, W Drobyski, ... Bone marrow transplantation 26 (5), 511-516, 2000 | 290 | 2000 |
| A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study JE Levine, TM Braun, AC Harris, E Holler, A Taylor, H Miller, J Magenau, ... The Lancet Haematology 2 (1), e21-e29, 2015 | 287 | 2015 |
| Elafin is a biomarker of graft-versus-host disease of the skin S Paczesny, TM Braun, JE Levine, J Hogan, J Crawford, B Coffing, ... Science translational medicine 2 (13), 13ra2-13ra2, 2010 | 287 | 2010 |
| A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality ML MacMillan, M Robin, AC Harris, TE DeFor, PJ Martin, A Alousi, VT Ho, ... Biology of Blood and Marrow Transplantation 21 (4), 761-767, 2015 | 274 | 2015 |
| An early-biomarker algorithm predicts lethal graft-versus-host disease and survival MJ Hartwell, U Özbek, E Holler, AS Renteria, H Major-Monfried, P Reddy, ... JCI insight 2 (3), 2017 | 235 | 2017 |
| Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease JE Levine, S Paczesny, S Mineishi, T Braun, SW Choi, RJ Hutchinson, ... Blood, The Journal of the American Society of Hematology 111 (4), 2470-2475, 2008 | 235 | 2008 |
| Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant … AM Alousi, DJ Weisdorf, BR Logan, J Bolanos-Meade, S Carter, ... Blood, The Journal of the American Society of Hematology 114 (3), 511-517, 2009 | 233 | 2009 |
| Pathogenesis and management of graft-versus-host disease SW Choi, JE Levine, JLM Ferrara Immunology and Allergy Clinics 30 (1), 75-101, 2010 | 216 | 2010 |
Thomas M. BraunProfessor of Biostatistics, University of MichiganVerified email at umich.edu
